
Please try another search
Divi's Laboratories Limited reported earnings results for the nine months ended December 31, 2022. For the nine months, the company reported sales was INR 58,167.4 million compared to INR 64,413.9 million a year ago. Revenue was INR 60,994.6 million compared to INR 65,028.7 million a year ago. Net income was INR 15,024.1 million compared to INR 20,658.1 million a year ago. Basic earnings per share from continuing operations was INR 56.6 compared to INR 77.82 a year ago. Diluted earnings per share from continuing operations was INR 56.6 compared to INR 77.82 a year ago.
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 17076.8 | 18545.4 | 22545.2 | |
Gross Profit | 9681.3 | 11799.1 | 14425.6 | |
Operating Income | 3215.1 | 5353.1 | 7630.4 | |
Net Income | 3068 | 4936 | 7020.1 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 135182.6 | 133747.1 | ||
Total Liabilities | 13835.8 | 16465.3 | ||
Total Equity | 121346.8 | 117281.8 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 19118 | |||
Cash From Investing Activities | -21949.2 | |||
Cash From Financing Activities | -5324.4 | |||
Net Change in Cash | -8155.6 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review